China National Medicines Stock Short Ratio
| 600511 Stock | 31.25 1.08 3.34% |
China National Medicines fundamentals help investors to digest information that contributes to China National's financial success or failures. It also enables traders to predict the movement of China Stock. The fundamental analysis module provides a way to measure China National's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China National stock.
China | Short Ratio |
China National Medicines Company Short Ratio Analysis
China National's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, China National Medicines has a Short Ratio of 0.0 times. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
China Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0436 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 16.76 B | ||||
| Shares Outstanding | 754.5 M | ||||
| Shares Owned By Insiders | 57.04 % | ||||
| Shares Owned By Institutions | 12.10 % | ||||
| Price To Book | 1.47 X | ||||
| Price To Sales | 0.46 X | ||||
| Revenue | 49.7 B | ||||
| Gross Profit | 3.82 B | ||||
| EBITDA | 2.41 B | ||||
| Net Income | 2.15 B | ||||
| Total Debt | 268.35 M | ||||
| Book Value Per Share | 22.01 X | ||||
| Cash Flow From Operations | 2.73 B | ||||
| Earnings Per Share | 2.87 X | ||||
| Target Price | 44.16 | ||||
| Number Of Employees | 3.14 K | ||||
| Beta | 0.5 | ||||
| Market Capitalization | 23.72 B | ||||
| Total Asset | 32.45 B | ||||
| Retained Earnings | 12.03 B | ||||
| Working Capital | 14.38 B | ||||
| Net Asset | 32.45 B | ||||
| Last Dividend Paid | 0.85 |
About China National Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China National Medicines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China National using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China National Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in China Stock
China National financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China National security.